Seer

Seer is a life sciences company committed to empowering exceptional scientific outcomes by eliminating various technical barriers between breakthrough ideas and the deep, unbiased proteomic information that can make them a reality. Seer is developing its Proteograph™ product suite, which includes reagents, instruments, and software, to provide researchers with an automated and easily scalable solution to access and harness the richness of the proteome, a capability that is currently lacking. They believe that unbiased, large-scale proteomics can and must become a reality to unlock the potential of biology and disease treatment. Their solution will enable fundamental and translational researchers to view the proteome through an entirely new lens without compromising their ability to see the richness and diversity of the proteome as it manifests in individuals—precisely where groundbreaking biological discoveries can begin.